Spellberg, B
A small 2024/2025 pilot study evaluated the acute intravenous infusion of BPC-157 (dosed at 10mg followed by 20mg the next day) in merely two healthy human adults
Cole LK, Zhang M, Chen L, Sparagna GC, Vandel M, Xiang B, et al
LDX, like all amphetamine stimulants, has direct appetite suppressant effects that may be therapeutically useful in BED, although long-term neuroadaptations in dopaminergic and noradrenergic systems caused by LDX may also be relevant, leading to improved regulation of eating behaviours, attentional processes and goal-directed behaviours
Chem Sci Rev Lett 9(33):5866 Monteiro R, Azevedo I (2010) Chronic inflammation in obesity and the metabolic syndrome
Warnings and Precautions Toujeo contains the same active ingredient, insulin glargine, as Lantus